"The Baltimore VA Medical Center is the acute medical and surgical care facility for the VA Maryland Health Care System and offers a full range of inpatient, outpatient and primary care services. The Baltimore VA Medical Center serves at the neurosurgery referral center for the VA Capitol Health Care Network. The medical center's patient-friendly design features plant-filled atriums, natural light from overhead skylights and comfortable patient rooms and waiting areas. Located next to the University of Maryland Medical Center with a walkway connecting the two facilities, the medical center maintains an active affiliation with the university in the sharing of staff, resources and technology."

During the past decade, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 60 clinical trials were completed, i.e. on average, 98.4% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 30 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD" #1 sponsor was "VA Office of Research and Development" with 64 trials, followed by "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "University of Maryland, Baltimore" with 16 trials sponsored, "Baltimore VA Medical Center" with 11 trials sponsored and "US Department of Veterans Affairs" with 11 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "University of Maryland" with 6 trials as a collaborator, "Baltimore VA Medical Center" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD" are "Schizophrenia" (13 trials), "Stroke" (12 trials), "Lung Cancer" (10 trials), "Colorectal Cancer" (4 trials) and "Depression" (4 trials). Many other conditions were trialed in "Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD" in a lesser frequency.

Most popular intervention types in "Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD" are "Other" (57 trials), "Drug" (45 trials), "Behavioral" (42 trials), "Procedure" (12 trials) and "Device" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "carboplatin" (7 trials), "cisplatin" (6 trials), "Laboratory Biomarker Analysis" (5 trials) and "docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD" are 135 trials for "All" genders, 8 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are 44 active trials in "Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD". 4 are not yet recruiting, 20 are recruiting, 19 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 88 completed trials in Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, 4 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 78 trials that are defined as “Not Applicable".